Brief: Avrobio Announces Agreement To Sell gene therapy program to Novartis For $87.5 Million

Tectonic Therapeutic

22/05/2023 13:05

May 22 (Reuters) - AVROBIO Inc  AVRO.O :
    * AVROBIO ANNOUNCES AGREEMENT TO SELL CYSTINOSIS GENE
THERAPY
PROGRAM FOR $87.5 MILLION
    * AVROBIO INC - PROPOSED DEAL FOR ALL-CASH TRANSACTION, WITH
FULL
$87.5 MILLION TO BE PAID AT CLOSING
    * AVROBIO INC - PROCEEDS EXPECTED TO EXTEND CASH RUNWAY INTO
Q4
2024

Source text for Eikon:  ID:nBw5jZZ3Ca 
Further company coverage:  AVRO.O 

 ((Reuters.Briefs@thomsonreuters.com;))